These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8568321)
21. Intravascular catheters impregnated with antimicrobial agents: a milestone in the prevention of bloodstream infections. Raad I; Hanna H Support Care Cancer; 1999 Nov; 7(6):386-90. PubMed ID: 10541979 [TBL] [Abstract][Full Text] [Related]
22. In vivo efficacy of antimicrobial-coated fabric from prosthetic heart valve sewing rings. Darouiche RO; Meade R; Mansouri M; Raad II J Heart Valve Dis; 1998 Nov; 7(6):639-46. PubMed ID: 9870198 [TBL] [Abstract][Full Text] [Related]
23. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter. Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302 [TBL] [Abstract][Full Text] [Related]
24. In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria. Yorganci K; Krepel C; Weigelt JA; Edmiston CE Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):379-84. PubMed ID: 12072923 [TBL] [Abstract][Full Text] [Related]
25. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. Fraser JF; Bodman J; Sturgess R; Faoagali J; Kimble RM Burns; 2004 Feb; 30(1):35-41. PubMed ID: 14693084 [TBL] [Abstract][Full Text] [Related]
26. In vitro antimicrobial activity of a new antiseptic central venous catheter. Li C; Zhang X; Whitbourne R J Biomater Appl; 1999 Jan; 13(3):206-23. PubMed ID: 9934626 [TBL] [Abstract][Full Text] [Related]
27. In Vitro and In Vivo Effectiveness of an Innovative Silver-Copper Nanoparticle Coating of Catheters To Prevent Methicillin-Resistant Staphylococcus aureus Infection. Ballo MK; Rtimi S; Pulgarin C; Hopf N; Berthet A; Kiwi J; Moreillon P; Entenza JM; Bizzini A Antimicrob Agents Chemother; 2016 Sep; 60(9):5349-56. PubMed ID: 27353266 [TBL] [Abstract][Full Text] [Related]
28. Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria. Schmitt SK; Knapp C; Hall GS; Longworth DL; McMahon JT; Washington JA J Clin Microbiol; 1996 Mar; 34(3):508-11. PubMed ID: 8904403 [TBL] [Abstract][Full Text] [Related]
29. Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination. Darouiche RO; Mansouri MD; Gawande PV; Madhyastha S J Antimicrob Chemother; 2009 Jul; 64(1):88-93. PubMed ID: 19447791 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit. Osma S; Kahveci SF; Kaya FN; Akalin H; Ozakin C; Yilmaz E; Kutlay O J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824 [TBL] [Abstract][Full Text] [Related]
31. High incidence of line-related infection and mechanical failure of an antiseptic impregnated central venous catheter in highly immunocompromised patients. Ellis ME; Rhydderch D; Zwaan F; Guy ML; Baillie F Scand J Infect Dis; 1996; 28(1):91-3. PubMed ID: 9122642 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the silver iontophoretic catheter in an animal model. Hachem RY; Wright KC; Zermeno A; Bodey GP; Raad II Biomaterials; 2003 Sep; 24(20):3619-22. PubMed ID: 12809792 [TBL] [Abstract][Full Text] [Related]
33. Prevention of catheter related bloodstream infection by silver iontophoretic central venous catheters: a randomised controlled trial. Bong JJ; Kite P; Wilco MH; McMahon MJ J Clin Pathol; 2003 Oct; 56(10):731-5. PubMed ID: 14514774 [TBL] [Abstract][Full Text] [Related]
34. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation. Maaskant JM; De Boer JP; Dalesio O; Holtkamp MJ; Lucas C Eur J Cancer Care (Engl); 2009 Sep; 18(5):477-82. PubMed ID: 19453696 [TBL] [Abstract][Full Text] [Related]